We also identified that the dysfunctional activation of the Wnt/β-catenin pathway regulating the NTS-induced EMT and tumor invasion in HCC which could be suppressed significantly both in vitro and in vivo through target therapy against NTS signaling, such as the specific antagonist against NTR1 SR48692. The gene discussed is NTSR1; the disease is hepatocellular carcinoma.